MEDICOX Co., Ltd. Factory land and building in Gyeongsangnam-do to be disposed of for KRW 5.8 billion
MAI summary · Not investment advice
MEDICOX Co., Ltd. will dispose of factory land and buildings in Gyeongsangnam-do for KRW 5.8 billion, with a book value equal to 10.39% of total assets.
Key facts
- Asset type
- Land and buildings
- Asset
- Factory land and buildings at 651 Gamseo-ri, Georyu-myeon, Gyeongsangnam-do
- Disposal amount
- KRW 8.5 billionBook value as of 2026.06.30 · 10.39% of total assets
- % of total assets
- 10.39%Based on book value
- Counterparty
- A marine equipment distributorWholesale, retail and trading of shipbuilding equipment
- External valuation opinion
- FairExternal accounting firm · appraised value KRW 7.6 billion
- Board resolution date
- Oct 14, 2026
Commentary
AI commentary · Not investment advice
What happened
MEDICOX agreed to dispose of factory land and buildings in Georyu-myeon, Gyeongsangnam-do, to a marine equipment distributor. The total sale price is KRW 5.8 billion, with building VAT of KRW 105.0 million paid separately. A KRW 575.0 million down payment comes first, and the KRW 5.2 billion balance is due on 2026.11.13. The company plans to use the money to repay loans secured by the factory and to fund operations.
In the company's terms
The assets have a book value of KRW 8.5 billion, or 10.39% of total assets (KRW 81.4 billion, 2024.12.31 consolidated). The 2024 figure was used because the auditor issued a disclaimer of opinion on the 2025 statements. The sale price is 24.51% below the appraised value of KRW 7.6 billion. The company cited its need to repay debt and the price negotiation. It projects a loss on disposal of about KRW 2.7 billion.
What changes for shareholders
The factory secures a loan from a savings bank. The company plans to repay that loan in full and release the collateral once it receives the balance.
Show Korean comments
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist